Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Pain ; 139(3): 603-609, 2008 Oct 31.
Article in English | MEDLINE | ID: mdl-18614289

ABSTRACT

Fast Inhibitory controls mediated by glycine (GlyRs) and GABAA receptors (GABAARs) play an important role to prevent the apparition of pathological pain symptoms of allodynia and hyperalgesia. The use of positive allosteric modulators of these receptors, specifically expressed in the spinal cord, may represent an interesting strategy to limit or block pain expression. In this study, we have used stereoisomers of progesterone metabolites, acting only via non-genomic effects, in order to evaluate the contribution of GlyRs and GABAARs for the reduction of mechanical and thermal heat hypernociception. We show that 3alpha neurosteroids were particularly efficient to elevate nociceptive thresholds in naive animal. It also reduced mechanical allodynia and thermal heat hyperalgesia in the carrageenan model of inflammatory pain. This effect is likely to be mediated by GABAA receptors since 3beta isomer was inefficient. More interestingly, 3alpha5beta neurosteroid was only efficient on mechanical allodynia while having no effect on thermal heat hyperalgesia. We characterized these paradoxical effects of 3alpha5beta neurosteroid using the strychnine and bicuculline models of allodynia. We clearly show that 3alpha5beta neurosteroid exerts an antinociceptive effect via a positive allosteric modulation of GABAARs but, at the same time, is pronociceptive by reducing GlyR function. This illustrates the importance of the inhibitory amino acid receptor channels and their allosteric modulators in spinal pain processing. Moreover, our results indicate that neurosteroids, which are synthesized in the dorsal horn of the spinal cord and have limited side effects, may be of significant interest in order to treat pathological pain symptoms.


Subject(s)
Analgesics, Non-Narcotic/therapeutic use , Hyperalgesia/drug therapy , Pain Threshold/drug effects , Pregnanolone/therapeutic use , Receptors, GABA-A/drug effects , Receptors, Glycine/drug effects , Allosteric Regulation , Analgesics, Non-Narcotic/pharmacology , Animals , Bicuculline/toxicity , Carrageenan/toxicity , Drug Evaluation, Preclinical , Hot Temperature/adverse effects , Hyperalgesia/physiopathology , Inflammation/chemically induced , Inflammation/drug therapy , Inflammation/physiopathology , Male , Molecular Conformation , Pain Threshold/physiology , Pregnanolone/chemistry , Pregnanolone/pharmacology , Rats , Rats, Sprague-Dawley , Spinal Cord/drug effects , Stereoisomerism , Structure-Activity Relationship , Strychnine/toxicity , Touch
2.
J Neurochem ; 98(5): 1423-31, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16787404

ABSTRACT

DeltaFosB, a stable splice variant of FosB, has been proposed to mediate persistent brain adaptation in response to several chronic perturbations, but it has not yet been considered in the context of sustained pain. Inflammatory pain induces neuronal plasticity that can result in persistent alteration of nociceptive pathways. This neuronal plasticity can partly result from changes in gene expression controlled by transcription factors. In the present study, we analyse the capacity of carrageenan-mediated inflammation to induce DeltaFosB in the spinal cord. We found that hind-paw inflammation increases FosB-like immunoreactivity in the superficial layers of rat lumbar spinal cord for at least 7 days. This induction parallels mechanical hyperalgesia and is maximal in the dorsal horn of segment L4 of the spinal cord which corresponds to the primary nociceptive afferent regions from the hind paw. We identified this FosB-like signal as DeltaFosB by comparing data obtained with antibodies raised against either an epitope present in both FosB and DeltaFosB, or the FosB C-terminal region that is deleted in DeltaFosB. The week-lasting changes in DeltaFosB highlight the interest in this protein as a molecular marker of sustained pain, and suggest a role of this transcription factor in pain-related plasticity within the spinal cord.


Subject(s)
Inflammation/complications , Pain/etiology , Pain/metabolism , Proto-Oncogene Proteins c-fos/metabolism , Analysis of Variance , Animals , Body Weight/drug effects , Carrageenan , Extremities/pathology , Extremities/physiopathology , Functional Laterality , Immunohistochemistry/methods , Inflammation/chemically induced , Male , Neurons/drug effects , Neurons/metabolism , Pain/pathology , Pain Measurement/methods , Pain Threshold/drug effects , Rats , Rats, Sprague-Dawley , Spinal Cord/pathology , Time Factors
3.
J Pain ; 7(1): 32-9, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16414552

ABSTRACT

UNLABELLED: Devices designed for mechanical pain threshold studies are often difficult to implement. The purpose of this study was to investigate a simple tool based on calibrated forceps to induce quantifiable mechanical stimulation in the rat on a linear scale. The most suitable protocol was tested by determining the effects of 3 repetitive measurements on both hind paws, respectively, during long-term (9 days), mid-term (1 day), and short-term (2 hours). Only threshold increase related to weight gain over long-term was observed, suggesting that moderate rat training can be used. The capacity of the device to reveal hyperalgesia was tested in a model of carrageenan-induced inflammation in the hind paw. The hyperalgesia was maximal 6 hours after carrageenan injection and progressively decreased. Similar, although more variable, responses were observed with von Frey filaments. Morphine-induced analgesia resulted in a dose-dependent increase of paw threshold. Tolerance to morphine administrated on a once daily schedule (10 mg/kg) during 5 days was revealed by a significant decrease in analgesia by day 3. Taken together, these results demonstrated accuracy of this device for easy, fast, and reproducible measure of mechanical pain threshold on rat limbs. Moreover, it allows the performance of rat testing with minimal constraint, which reduces data variability. PERSPECTIVE: The calibrated forceps is an easy to use device well-suited to rapidly test mechanical pain threshold with accuracy. It is well-designed for preclinical behavioral screening of noxious or analgesic properties of molecules.


Subject(s)
Analgesics, Opioid/therapeutic use , Hyperalgesia/diagnosis , Hyperalgesia/drug therapy , Morphine/therapeutic use , Pain Measurement/instrumentation , Animals , Calibration , Carrageenan , Hyperalgesia/chemically induced , Male , Pain Threshold , Rats , Rats, Sprague-Dawley , Reproducibility of Results , Sensitivity and Specificity
4.
Eur J Neurosci ; 18(5): 1295-305, 2003 Sep.
Article in English | MEDLINE | ID: mdl-12956728

ABSTRACT

The central extended amygdala, a forebrain macrostructure, may represent a common substrate for acute drug reward and the dysphoric effects of drug withdrawal. To test its involvement during opiate withdrawal, we studied the distribution of c-Fos immunoreactive neurons, in relation to their neuropeptide content, in brain sections from morphine-dependent or naive rats, killed 90 min after naloxone or saline intraperitoneal injection. Naloxone treatment in naive rats induced a slight increase in c-Fos immunoreactivity in the central amygdaloid nucleus, the lateral bed nucleus of the stria terminalis and the interstitial nucleus of the posterior limb of the anterior commissure. In morphine-dependent rats, naloxone injection significantly increased the number of c-Fos-positive neurons in these structures as well as in the majority of the other central extended amygdala components. Double immunocytochemistry was used to determine the neurochemical nature of c-Fos-positive neurons in the central extended amygdala. Corticotropin-releasing factor- and methionine-enkephakin-immunoreactive neurons displayed c-Fos immunoreactivity in naive rats after naloxone injection, whereas only enkephalinergic neurons were found to be c-Fos positive in morphine-dependent rats after naloxone injection. The possible involvement of the corticotropin-releasing factor system during withdrawal is discussed. These results suggest that the whole central extended amygdala is activated during opiate withdrawal, with a lateral to medial decreasing gradient, and emphasize the role of peptidergic systems in this morphofunctional continuum.


Subject(s)
Amygdala/metabolism , Morphine Dependence/metabolism , Naloxone/pharmacology , Narcotic Antagonists/pharmacology , Proto-Oncogene Proteins c-fos/metabolism , Substance Withdrawal Syndrome/metabolism , Amygdala/anatomy & histology , Amygdala/drug effects , Animals , Behavior, Animal , Colchicine/pharmacology , Corticotropin-Releasing Hormone/metabolism , Enkephalin, Methionine/metabolism , Gout Suppressants/pharmacology , Male , Morphine Dependence/drug therapy , Naloxone/therapeutic use , Narcotic Antagonists/therapeutic use , Neurons/metabolism , Rats , Rats, Wistar
5.
J Cereb Blood Flow Metab ; 22(4): 367-78, 2002 Apr.
Article in English | MEDLINE | ID: mdl-11919508

ABSTRACT

Water homeostasis in the brain is of central physiologic and clinical importance. Neuronal activity and ion water homeostasis are inextricably coupled. For example, the clearance of K+ from areas of high neuronal activity is associated with a concomitant water flux. Furthermore, cerebral edema, a final common pathway of numerous neurologic diseases, including stroke, may rapidly become life threatening because of the rigid encasement of the brain. A water channel family, the aquaporins, facilitates water flux through the plasma membrane of many cell types. In rodent brain, several recent studies have demonstrated the presence of different types of aquaporins. Aquaporin 1 (AQP1) was detected on epithelial cells in the choroid plexus whereas AQP4, AQP5 and AQP9 were localized on astrocytes and ependymal cells. In rodent brain, AQP4 is present on astrocytic end-feet in contact with brain vessels, and AQP9 is found on astrocytic processes and cell bodies. In basal physiologic conditions, AQP4 and AQP9 appear to be implicated in brain homeostasis and in central plasma osmolarity regulation. Aquaporin 4 may also play a role in pathophysiologic conditions, as shown by the reduced edema formation observed after water intoxication and focal cerebral ischemia in AQP4-knockout mice. Furthermore, pathophysiologic conditions may modulate AQP4 and AQP9 expression. For example, AQP4 and AQP9 were shown to be upregulated after ischemia or after traumatic injuries. Taken together, these recent reports suggest that water homeostasis in the brain is maintained by regulatory processes that, by control of aquaporin expression and distribution, induce and organize water movements. Facilitation of these movements may contribute to the development of edema formation after acute cerebral insults such as ischemia or traumatic injury.


Subject(s)
Aquaporins/metabolism , Brain/metabolism , Water/metabolism , Animals , Aquaporins/chemistry , Brain/cytology , Brain/physiopathology , Cerebrospinal Fluid/metabolism , Homeostasis , Humans , Models, Neurological , Osmolar Concentration
SELECTION OF CITATIONS
SEARCH DETAIL
...